HMD — Hera Med Cashflow Statement
0.000.00%
- AU$14.01m
- AU$11.04m
- AU$0.36m
Annual cashflow statement for Hera Med, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Changes in Working Capital | 0.009 | 0.001 | 0.025 | 0.022 | 0.009 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.04 | -4.31 | -3.69 | -5.71 | -4.81 |
Capital Expenditures | -0.098 | -0.114 | -0.996 | -0.002 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.098 | -0.114 | -0.996 | -0.002 | 0 |
Financing Cash Flow Items | 0 | -0.159 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.66 | 6.51 | 3.66 | 3.04 | 6.88 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.206 | 2.21 | -1.36 | -2.88 | 2.07 |